Tumor-associated macrophages (TAMs) modulate response to HER2-targeted agents in a humanized mouse model of breast cancer

MLA

M. Loi, et al. “Tumor-Associated Macrophages (TAMs) Modulate Response to HER2-Targeted Agents in a Humanized Mouse Model of Breast Cancer.” Clinical and Translational Oncology, vol. 24, Feb. 2022, pp. 1395–402. EBSCOhost, https://doi.org/10.1007/s12094-022-02785-z.

APA

M. Loi, G. Salvatore, M. Sottili, L. Calosi, I. Desideri, C. Becherini, V. Salvestrini, L. P. Ciccone, G. Stocchi, I. Meattini, G. Francolini, M. Mangoni, & L. Livi. (2022). Tumor-associated macrophages (TAMs) modulate response to HER2-targeted agents in a humanized mouse model of breast cancer. Clinical and Translational Oncology, 24, 1395–1402. https://doi.org/10.1007/s12094-022-02785-z

Chicago

M. Loi, G. Salvatore, M. Sottili, L. Calosi, I. Desideri, C. Becherini, V. Salvestrini, et al. 2022. “Tumor-Associated Macrophages (TAMs) Modulate Response to HER2-Targeted Agents in a Humanized Mouse Model of Breast Cancer.” Clinical and Translational Oncology 24 (February): 1395–1402. doi:10.1007/s12094-022-02785-z.